Glucagon-Like Peptide 1 Stimulates Lipolysis in Clonal Pancreatic β-Cells (HIT)

Glucagon-Like Peptide 1 Stimulates Lipolysis in Clonal Pancreatic β-Cells (HIT) Gordon C. Yaney , Vildan N. Civelek , Ann-Marie Richard , Joseph S. Dillon , Jude T. Deeney , James A. Hamilton , Helen M. Korchak , Keith Tornheim , Barbara E. Corkey and Aubrey E. Boyd III From the Obesity Research Cen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2001-01, Vol.50 (1), p.56-62
Hauptverfasser: YANEY, Gordon C, CIVELEK, Vildan N, RICHARD, Ann-Marie, DILLON, Joseph S, DEENEY, Jude T, HAMILTON, James A, KORCHAK, Helen M, TORNHEIM, Keith, CORKEY, Barbara E, BOYD, Aubrey E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Glucagon-Like Peptide 1 Stimulates Lipolysis in Clonal Pancreatic β-Cells (HIT) Gordon C. Yaney , Vildan N. Civelek , Ann-Marie Richard , Joseph S. Dillon , Jude T. Deeney , James A. Hamilton , Helen M. Korchak , Keith Tornheim , Barbara E. Corkey and Aubrey E. Boyd III From the Obesity Research Center (G.C.Y., V.N.C., A.-M.R, J.T.D., J.A.H., K.T., B.E.C.), Evans Department of Medicine, and the Departments of Biochemistry (B.E.C., K.T.) and Biophysics (J.A.H.), Boston Medical Center, Boston, Massachusetts; the Division of Endocrinology (J.S.D.), University of Iowa School of Medicine, Iowa City, Iowa; and the Immunology Division (H.M.K.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Address correspondence and reprint requests to Dr. Barbara E. Corkey, Obesity Research Center, EBRC-808, Boston Medical Center, 650 Albany St., Boston, MA 02118. E-mail: bcorkey{at}med-med1.bu.edu . Abstract Glucagon-like peptide 1 (GLP-1) is the most potent physiological incretin for insulin secretion from the pancreatic β-cell, but its mechanism of action has not been established. It interacts with specific cell-surface receptors, generates cAMP, and thereby activates protein kinase A (PKA). Many changes in pancreatic β-cell function have been attributed to PKA activation, but the contribution of each one to the secretory response is unknown. We show here for the first time that GLP-1 rapidly released free fatty acids (FFAs) from cellular stores, thereby lowering intracellular pH (pH i ) and stimulating FFA oxidation in clonal β-cells (HIT). Similar changes were observed with forskolin, suggesting that stimulation of lipolysis was a function of PKA activation in β-cells. Triacsin C, which inhibits the conversion of FFAs to long-chain acyl CoA (LC-CoA), enhanced basal FFA efflux as well as GLP-1-induced acidification and efflux of FFAs from the cell. Increasing the concentration of the lipase inhibitor orlistat progressively and largely diminished the increment in secretion caused by forskolin. However, glucose-stimulated secretion was less inhibited by orlistat and only at the highest concentration tested. Because the acute addition of FFAs also increases glucose-stimulated insulin secretion, these data suggest that the incretin function of GLP-1 may involve a major role for lipolysis in cAMP-mediated potentiation of secretion. Footnotes A.E.B. is deceased. ACS, acyl CoA synthetase; AM, acetoxymethyl ester; BCECF, 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluor
ISSN:0012-1797
1939-327X
DOI:10.2337/diabetes.50.1.56